Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
When theoretically, should the FDA meeting be held ? I was thinking it would be after the trial was completely finished. So you all are saying it would be as the combo trial is winding down ? And this would be ok because CYDY is allowed a rolling BLA submission ?
Very well. Keep in mind that I am not saying it *IS* crazy, just that it *sounds* that way. I have invested my and some of my late parents money in the hopes of such a large buyout.
If there already is an offer in place, it can’t be THAT high. Why would say a Gilead (or whoever) put an offer of 20 to 50 times the current market cap of a company ? That sounds insane.
You mean wisdom like, “Puke or die now !” ? Yes, I’ve noticed his / her absence. ??
Wow, he only recommended 25 stocks between CT and CY.
Huh ?
Would you agree that most of the Paulson investors have no clue about the value of CYDY. I now imagine that most nearly indiscriminately go around from company to company picking up warrants and selling off shares, having NO CLUE which of these companies if any will hit it big. Trying to collect as many lotto tickets as possible. Previously I had thought of them as more selective. I continue to become ever more jaded, as if that were possible.
Check the # if employees, CYDY can’t go it alone !?
To be honest, I have zero expectation that presentation of phase 3 results (without the company announcing something afterwards) will do anything lasting pricewise next week. Yes, I am long but conferences have done exactly nothing before. I’m a realist; We are OTC. If there’s any volume Paulson people will be selling like crazy. The market can be stupid and persist in its stupidity. Now if we have 10+ Mill shares traded, then I’d change my tune.
You have been silent on all of IHub for a year and half and you come here to say this. Interesting.
Any PR, presuming there is one, might be delayed until Monday. If not, there will be a hounding of their PR offices by this msg board.
Yes, but how long will that continue ? June presentation ? Mtg with FDA ?
The can present primary efficacy results but no complete results which require 6 months of follow up. They could present incomplete results, I suppose ?
“I still believe there is a concerted effort to suppress SP. “. My pessimistic and warped mind has thought that for about a year. Stop it !
What would be the reason that this internet rumor have more credibility than the average internet rumor ? I can see that this could possibly be true, but what makes it different ?
Agenda explains so much in other sectors of society and life in general, I can’t imagine the markets being any different. How could they NOT be influenced by agendas ?
“Unless we get to a real exchange like KTOV is on, how can we have an explosive day trading millions of shares? “
That won’t happen on OTC. For an organic rise to $4, the company would have to get up to ... $1.5 B mkt cap. Then the company would have to raise cash for cap requirements. It will take a partnership or BLA, IMO. We will be on OTC a while longer, but not forever.
And the group of shareholders on this board appreciate the insult. You have to call yourself terrific because no one else will.
I can find no mention of Pro140 or Cytodyn anywhere on the ASM website. I suppose that’s because they are a late breaker.
Welcome back, Grip !
Picked up a bunch more at 0.48
Thanks Sandra for presenting your methodologies and formulas, and documenting everything. All of this is new ground for me. It’s delightful to see some rationale for the company’s possible future value.
Ok, you are talking peak revenue. But most other products aren’t near as “lumpy” in terms of revenue. That could make comparisons difficult to CYDY.
But didn’t Pharmassets Hep-C bring in about $65 Billion revenue for Gilead .... and counting ? $20 Billion at least for 2 different years.
50% success over 3 years for a MONO therapy .... is amazing and unprecedented, I think.
Thanks misiu !
Ok, thanks trding !
This article showed that one patient had an SAE. A transient ischemic attack. Wikipedia says a synonym is a mini-stroke. Fortunately only one patient had this, but does this raise a reason for concern ?
But there are tens of millions more shares out there, IMO. The company will continue (and has no other real choice) to issue more. Until tens of millions of shares (or however many) are bought, this will unfortunately continue.
Back down to 51
I drink BECAUSE of CYDY. Just kidding
Just picked up another big chunk at 49.9 cents.
“As one wise investor stated long ago on this forum, you may want to manage your energy on a monthly basis rather than a daily basis with this type of investment or you will become fatigued. “
< light bulb > Ahhh, that’s one of the places where I messed up.
Thanks.
Which step along the way is likely the trigger ? BLA filing ? BLA acceptance ? But combo still requires a years worth (or 6 months ?) of safety data from 300 patients mostly from the Mono trial, right ? That would seem to mean combo is about a year or so from completion.
I had to navigate back from the front page to get the CYDY article.
I want to see those metastatic cancer preclinical trials.
No I didn’t thanks. Mcap 70 * $3.40 = $238 Mill. Cash $36 + $75 = $111 Mill.
Trading for 1.5 times cash. Did I mis-calculate ?
Looks very interesting. Multiple shots on goal; extra cash. Will keep my eye on meip. I’ve been spending my time and losing money on CYDY. Hopefully, things will rebound soon at ASM.